DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Ro's Body program connects users with prescribers for Wegovy, Zepbound, and compounded options.
Ro Body is worth considering for people who want a vetted, US-based way to get prescribed FDA-approved weight-loss injections with real clinical support and help navigating insurance. The medications it prescribes have strong randomized-trial evidence behind them. The catch: you pay a recurring membership fee on top of medication, the drug cost (not the app) is what matters most, and a clinician decides whether you qualify.
Ro Body itself is a service layer, not a drug. You complete an online intake, a licensed clinician reviews your history, and, if appropriate, prescribes an FDA-approved GLP-1 (or dual GLP-1/GIP) medication such as Wegovy or Ozempic (semaglutide) or Zepbound (tirzepatide). These medicines mimic gut hormones that signal fullness to the brain, slow stomach emptying, and reduce appetite and food cravings, so most people eat less and lose weight. Ro layers on monthly provider check-ins, unlimited messaging, registered-nurse coaching, a behavior-change curriculum, dose-titration support, and an insurance concierge that submits prior authorizations to help you pursue coverage.
Active ingredient: Semaglutide / Tirzepatide (brand or compounded)
Ro cites average weight loss of roughly 15% of body weight over a year, a figure that tracks the medications' pivotal trials rather than a separate Ro study. In the STEP 1 trial (Wilding et al., NEJM 2021; n=1,961), once-weekly semaglutide 2.4 mg (Wegovy) produced a mean 14.9% weight loss at 68 weeks versus 2.4% for placebo, with 86.4% of participants losing at least 5%. For tirzepatide (Zepbound), the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022; n=2,539) showed mean losses of 16.0%, 21.4%, and 22.5% at the 5, 10, and 15 mg doses versus 2.4% for placebo over 72 weeks. These results reflect the medication combined with lifestyle change, and weight tends to return after stopping. Individual results vary.
The most common side effects come from the GLP-1 medication, not the platform: nausea, vomiting, diarrhea, constipation, stomach pain, indigestion, gas, fatigue, and headache. These are usually mild to moderate, worst when starting or raising the dose, and tend to ease over time. Serious but less common risks include pancreatitis (severe, persistent abdominal pain), gallbladder problems and gallstones, kidney problems from dehydration, low blood sugar (especially if combined with insulin or a sulfonylurea), and, rarely, serious allergic reactions. Wegovy, Ozempic, and Zepbound carry an FDA boxed warning for thyroid C-cell tumors seen in rodents; whether this risk applies to humans is unknown. Stop the medication and seek care for severe stomach pain.
Starts at $135/mo from Ro.
As of 2026, Ro Body membership is about $45 the first month and roughly $145/month after, and is lower if you prepay annually (Ro's own site has listed figures closer to $39 first month and $149/month month-to-month, so confirm the current price at checkout). The membership fee is generally not covered by insurance, though HSA/FSA funds may apply. Medication is billed separately and is the bigger variable. If your insurance covers brand Wegovy or Zepbound, savings cards can bring your out-of-pocket cost down to as little as $0 to $25/month. Without coverage, cash-pay options through programs like NovoCare and LillyDirect have run roughly $300 to $500/month for self-pay vials or pens in 2026 (with introductory pricing as low as ~$199 for early Wegovy fills), and Ro advertises additional prepay savings. Confirm your specific drug, dose, and coverage before committing, because total out-of-pocket varies widely.
Membership $135/mo + medication cost separately.
Ro Body delivers physician-prescribed, FDA-approved GLP-1 therapy with genuine coaching and insurance support, a reasonable choice if you value convenience and guidance. Just go in clear-eyed: you pay a membership fee plus the medication, and total monthly cost can range from near-zero (if your insurance covers Wegovy or Zepbound) to several hundred dollars for cash-pay. The weight-loss results come from the medication, which generally works only while you keep taking it. This is not medical advice; talk to a clinician about whether a GLP-1 is right for you.
Yes. Ro is an established US telehealth company operating since 2017, using state-licensed clinicians and dispensing FDA-approved GLP-1 medications such as Wegovy, Zepbound, and Ozempic. It works with manufacturer programs like LillyDirect and NovoCare and routes prescriptions through pharmacies. Most customer complaints involve billing and shipping logistics rather than medical safety.
Ro Body membership is about $45 for the first month and roughly $145/month afterward (lower with annual prepay), and it is generally not covered by insurance. Ro's own site has also listed figures near $39 first month and $149/month, so confirm the current price. Medication is billed separately and ranges from near $0 with insurance coverage to roughly $300 to $500/month for cash-pay without coverage.
FDA-approved GLP-1 weight-loss medications, primarily Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide), plus newer brand formulations such as the orforglipron pill. Ro shifted away from compounded semaglutide toward brand-name drugs as FDA grace periods for GLP-1 compounding ended and the agency moved to restrict large-scale compounding in 2025 and 2026.
Ro cites an average of about 15% of body weight over a year, mirroring the medications' clinical trials. In STEP 1, semaglutide 2.4 mg produced about 14.9% weight loss at 68 weeks, and in SURMOUNT-1 tirzepatide produced up to about 22.5% at 72 weeks, both alongside lifestyle change. Individual results vary, and weight commonly returns after stopping the medication.
The monthly Ro Body membership fee itself is typically not covered by insurance. However, Ro's insurance concierge checks your plan and submits prior authorizations so your insurance can cover the GLP-1 medication at your pharmacy, which can dramatically lower drug cost. If you have no coverage, you can also use cash-pay options through programs like NovoCare and LillyDirect.
Most common are nausea, vomiting, diarrhea, constipation, and stomach pain, which are usually mild and improve over time. Less common but serious risks include pancreatitis, gallbladder problems, and kidney issues from dehydration, and the drugs carry an FDA boxed warning for thyroid C-cell tumors seen in rodents (human risk is unknown). Seek care for severe, persistent abdominal pain.
Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a prior serious reaction to the drug, or who is pregnant or breastfeeding should avoid GLP-1 therapy. People with a history of pancreatitis or gallbladder disease need caution. A clinician reviews your history and decides eligibility, and some applicants are turned down.
Usually not entirely. GLP-1 medications work while you take them, and studies show significant weight regain after stopping. For most people Ro Body is best viewed as a long-term treatment rather than a short-term fix, so factor in the ongoing medication and membership cost before starting.
It depends. Ro offers convenience, fast access, coaching, and insurance help, but charges a recurring membership fee. If your own doctor will prescribe a GLP-1 and your insurance covers it, going direct can be cheaper because you skip the platform fee. Ro's main value is in access, support, and help navigating prior authorizations.